Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
J.Jill | JILL | Sep 3, 2024 | 32.24 | -0.89 |
Jabil | JBL | Sep 3, 2024 | 103.41 | -5.37 |
Jack Henry & Associates | JKHY | Sep 3, 2024 | 175.08 | +1.18 |
Jack In The Box | JACK | Sep 3, 2024 | 46.91 | -4.96 |
Jackson Financial | JXN-A | Sep 3, 2024 | 26.42 | +0.08 |
Jackson Financial | JXN | Sep 3, 2024 | 85.67 | -4.78 |
Jacobs Engineering Group | J | Sep 3, 2024 | 147.15 | -2.47 |
Jaguar Health | JAGX | Sep 3, 2024 | 1.12 | -1.75 |
JAKKS Pacific | JAKK | Sep 3, 2024 | 23.85 | -3.21 |
James Hardie Industries ADR | JHX | Sep 3, 2024 | 36.82 | -1.58 |
James River Group Holdings | JRVR | Sep 3, 2024 | 7.02 | -5.14 |
Jamf | JAMF | Sep 3, 2024 | 17.70 | -4.32 |
Janover | JNVR | Sep 3, 2024 | 0.45 | -6.11 |
Janus Henderson Group | JHG | Sep 3, 2024 | 36.64 | -2.58 |
Janus International Group | JBI | Sep 3, 2024 | 10.59 | -3.64 |
Janus Small Cap Growth Alpha ETF | JSML | Sep 3, 2024 | 61.94 | -3.48 |
Janus Small/Mid Cap Growth Alpha ETF | JSMD | Sep 3, 2024 | 68.85 | -3.22 |
Janux Therapeutics | JANX | Sep 3, 2024 | 45.01 | -4.19 |
Japan Alphadex First Trust | FJP | Sep 3, 2024 | 53.58 | -0.25 |
Japan Hedged Equity Wisdomtree | DXJ | Sep 3, 2024 | 105.92 | -1.49 |
Japan Index MSCI Ishares | EWJ | Sep 3, 2024 | 70.89 | -1.50 |
Japan Smallcap Dividend Wisdomtree | DFJ | Sep 3, 2024 | 78.75 | -0.80 |
Japan Smallcap Index MSCI Ishares | SCJ | Sep 3, 2024 | 76.70 | -0.35 |
Japan Smaller Capitalization Fund | JOF | Sep 3, 2024 | 7.97 | -0.75 |
Japanese Yen Trust | FXY | Sep 3, 2024 | 63.49 | +0.33 |
Jasper Therapeutics A | JSPR | Sep 3, 2024 | 19.18 | -12.02 |
Jaws Mustang Acquisition A | JWSM | Sep 3, 2024 | 11.23 | 0.00 |
Jayud Global Logistics | JYD | Sep 3, 2024 | 0.73 | +7.37 |
Jazz Pharmaceuticals | JAZZ | Sep 3, 2024 | 109.32 | -5.74 |
JBG Smith Properties | JBGS | Sep 3, 2024 | 17.30 | -0.57 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.